文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

载药及释药性能研究 载药量及释药性能研究

Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.

机构信息

Department of Pharmaceutics, Shenyang Pharmaceutical University P.O. Box 32, 103 Wenhua Road, Shenhe District, Shenyang, Liaoning Province 110016, PR China.

出版信息

J Control Release. 2010 Aug 3;145(3):257-63. doi: 10.1016/j.jconrel.2010.04.029. Epub 2010 May 5.


DOI:10.1016/j.jconrel.2010.04.029
PMID:20450945
Abstract

The purpose of this study was to develop mesoporous silica nanoparticles (MSNs) loaded with a poorly water-soluble drug, intended to be orally administered, able to improve the dissolution rate and enhance the drug loading capacity. Spherical MSNs were synthesized using an organic template method in an oil/water phase, and large pore diameter MSNs were functionalized with aminopropyl groups through postsynthesis. MSNs as well as the resulting functionalized MSNs were investigated as matrices for loading and release of the model drug telmisartan (TEL). The effects of different pore sizes and surface chemical groups on TEL uptake and release were systematically studied using scanning electron microscopy (SEM), transmission electron microscopy (TEM), nitrogen adsorption, X-ray diffraction (XRD), Fourier transformation infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA) and HPLC. The total pore volume and the pore diameter of MSNs were the two main factors limiting the maximum drug load capacity. MSNs allow a very high drug loading of about 60% in weight. The release rate of TEL from MSNs with a pore diameter of 12.9 nm was found to be effectively increased and the release rate of TEL from the functionalized MSNs was effectively controlled compared with that from the unmodified MSNs. We believe that the present study will help in the design of oral drug delivery systems for the dissolution enhancement and/or sustained release of poorly water-soluble drugs.

摘要

本研究旨在开发载有疏水性药物的介孔硅纳米粒子(MSNs),用于口服给药,以提高药物的溶解速率并增强药物载量。采用油/水相中的有机模板法合成球形 MSNs,并通过后合成将大孔径 MSNs 功能化氨基丙基。将 MSNs 及其所得功能化 MSNs 作为模型药物替米沙坦(TEL)的负载和释放基质进行研究。使用扫描电子显微镜(SEM)、透射电子显微镜(TEM)、氮气吸附、X 射线衍射(XRD)、傅里叶变换红外光谱(FT-IR)、差示扫描量热法(DSC)、热重分析(TGA)和高效液相色谱法(HPLC)系统研究了不同孔径和表面化学基团对 TEL 摄取和释放的影响。MSNs 的总孔体积和孔径是限制最大药物载量能力的两个主要因素。MSNs 允许药物的载药量高达约 60%(重量)。与未修饰的 MSNs 相比,发现 12.9nm 孔径的 MSNs 中 TEL 的释放速率得到了有效提高,并且功能化 MSNs 中 TEL 的释放速率得到了有效控制。我们相信,本研究将有助于设计用于增强疏水性药物溶解和/或控制释放的口服药物递送系统。

相似文献

[1]
Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.

J Control Release. 2010-5-5

[2]
Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.

Mater Sci Eng C Mater Biol Appl. 2014-1-1

[3]
Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.

Mol Pharm. 2012-2-1

[4]
Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.

Eur J Pharm Biopharm. 2010-6-2

[5]
Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.

Int J Pharm. 2012-10-16

[6]
Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.

Colloids Surf B Biointerfaces. 2019-1-2

[7]
A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.

Int J Pharm. 2013-7-17

[8]
Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.

ACS Appl Mater Interfaces. 2012-12-24

[9]
The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.

J Biomater Sci Polym Ed. 2016

[10]
Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.

Int J Pharm. 2013-7-12

引用本文的文献

[1]
The Application of Mesoporous Silica Nanoparticles in Enhancing the Efficacy of Anti-Atherosclerosis Therapies: A Review.

Int J Nanomedicine. 2025-8-10

[2]
Design and fabrication of a mesoporous silica scaffold for oral delivery of peptides.

Sci Rep. 2025-8-12

[3]
Drug-Free Mesoporous Silica Nanoparticles Enable Suppression of Cancer Metastasis and Confer Survival Advantages to Mice with Tumor Xenografts.

ACS Appl Mater Interfaces. 2024-11-13

[4]
Dragon's Blood-Loaded Mesoporous Silica Nanoparticles for Rapid Hemostasis and Antibacterial Activity.

Molecules. 2024-4-21

[5]
Structural elucidation and development of azelaic acid loaded mesoporous silica nanoparticles infused gel: Revolutionizing nanodrug delivery for cosmetics and pharmaceuticals.

Heliyon. 2024-4-13

[6]
Ligand-Selective Targeting of Macrophage Hydrogel Elicits Bone Immune-Stem Cell Endogenous Self-Healing Program to Promote Bone Regeneration.

Adv Healthc Mater. 2024-4

[7]
In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation.

Pharmaceuticals (Basel). 2023-12-18

[8]
Mesoporous Particle Embedded Nanofibrous Scaffolds Sustain Biological Factors for Tendon Tissue Engineering.

ACS Mater Au. 2023-7-24

[9]
Ameliorative Effect of Thymoquinone and Thymoquinone Nanoparticles against Diazinon-Induced Hepatic Injury in Rats: A Possible Protection Mechanism.

Toxics. 2023-9-15

[10]
Critical Analysis and Optimization of Stoichiometric Ratio of Drug-Coformer on Cocrystal Design: Molecular Docking, In Vitro and In Vivo Assessment.

Pharmaceuticals (Basel). 2023-2-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索